Subcellular alteration of glyceraldehyde-3-phosphate dehydrogenase in Alzheimer's disease fibroblasts

Journal of Neuroscience Research

Volumn 71, Issue 2, 2003, Pages 279-285

  Mazzola, Jennifer L ^a   Sirover, Michael A ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

amyloid precursor protein; Alzheimer's disease; GAPDH; Glyceraldehyde 3 phosphate dehydrogenase; RNA; Subcellular localization

Indexed keywords

AMYLOID BETA PROTEIN; CELL EXTRACT; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PROTEIN PRECURSOR;

ALZHEIMER DISEASE; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; BIODIVERSITY; CELL STRUCTURE; CONTROLLED STUDY; CYTOPLASM; DISSOCIATION; ENERGY; ENZYME ACTIVITY; FIBROBLAST; GLYCOLYSIS; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; REDUCTION;

AGE FACTORS; ALZHEIMER DISEASE; BLOTTING, WESTERN; CELLS, CULTURED; FIBROBLASTS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; MATCHED-PAIR ANALYSIS; NAD; SUBCELLULAR FRACTIONS; TIME FACTORS;

EID: 0037438118     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10484     Document Type: Article

References (56)

1. Arenaz P, Sirover, MA. 1983. Isolation and characterization of monoclonal antibodies directed against the DNA repair enzyme uracil DNA glycosylase from human placenta. Proc Natl Acad Sci USA 80:5822-5826.
2. Barinaga M. 1996. An intriguing new lead on Huntington's disease. Science 271:1233-1234.
3. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
4. Burke JR, Enghild JJ, Martin ME, Jou Y-S, Myers RM, Roses AD, Vance JM, Strittmatter WJ. 1996. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nat Med 2:347-350.
5. Busciglio J, Yankner BA. 1995. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 378:776-779.
6. Carlile GW, Tatton WG, Borden KLB. 1998. Demonstration of a RNA-dependent nuclear interaction between the promyelocytic leukemia protein and glyceraldehyde-3-phosphate dehydrogenase. Biochem J 335:691-696.
7. Carlile GW, Chalmers-Redman RME, Tatton NA, Pong A, Borden KE, Tatton WG. 2000. Reduced apoptosis after nerve growth factor and serum withdrawal: Conversion of tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer. Mol Pharmacol 57:2-12.
8. Checler F. 1995. Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease. J Neurochem 65:1431-1444.
9. Cotman CW, Whittemore ER, Watt JA, Anderson, AJ, Loo DT. 1994. Possible role of apoptosis in Alzheimer's disease. Ann N Y Acad Sci 747:36-49.
10. Coyle JT, Price DL, DeLong MR. 1983. Alzheimer's disease: A disorder of cortical cholinergic innervation. Science 219:1184-1190.
11. Cupers P, Orlans I, Craessaerts K, Annaert W, De Strooper B. 2001. The amyloid precursor protein (APP)-cytoplasmic fragment generated by gamma-secretase is rapidly degraded but distributes partially in a nuclear fraction of neurones in culture. J Neurochem 78:68-78.
12. Dodart JC, Mathis C, Bales KR, Paul SM, Ungerer A. 1999. Early regional cerebral glucose hypometabolism in transgenic mice overexpressing the V717F beta-amyloid precursor protein. Neurosci Lett 277:49-52.
13. Gabuzda D, Busciglio J, Chen LB, Matsudaira P, Yankner BA. 1994. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J Biol Chem 269:13623-13628.
14. Gasparini L, Racchi M, Benussi L, Curti D, Binetti G, Bianchetti A, Trabucchi, M, Govoni S. 1997. Effect of energy shortage and oxidative stress on amyloid precursor protein metabolism in COS cells. Neurosci Lett 231:113-117.
15. Goldberg YP, Nicholson DW, Rasper DM, Kalchman MA, Koide HB, Graham RK, Bromm M, Kazemi-Esfarjani P, Thornberry NA, Vaillan-court JP, Hayden MR. 1996. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is mediated by the polyglutamine tract. Nat Genet 13:442-449.
16. Hoyer S. 1998. Risk factors for Alzheimer's disease during aging. Impact of glucose/energy metabolism. J Neural Transmiss 54(Suppl):187-194.
17. Ibanez V, Pietrini P, Alexander GE, Furey ML, Teichberg D, Rajapakse JC, Rapoport SI, Schapiro MB, Horwitz B. 1998. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology 50:1585-1593.
18. Ishitani R, Chuang D-M. 1996. Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinonucleoside-induced apoptosis in cultured cerebellar neurons. Proc Natl Acad Sci USA 93:9937-9941.
19. Ishitani R, Tanaka M, Sunaga K, Katsube N, Chuang D-M. 1998. Nuclear localization of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis. Mol Pharmacol 53:701-707.
20. Kimberly WT, Zheng JB, Guenette SY, Selkoe DJ. 2001. The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner. J Biol Chem 276:40288-40292.
21. Kish SJ, Lopes-Cendes I, Guttman M, Furukawa Y, Pandolfo M, Rouleau GA, Ross BM, Nance M, Schut L, Ang L, DiStefano L. 1998. Brain glyceraldehyde-3-phosphate dehydrogenase activity in human trinucleotide repeat disorders. Arch Neurol 55:1299-1304.
22. Koshy B, Matilla T, Burright EN, Merry DE, Fischbeck KH, Orr HT, Zoghbi HY. 1996. Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. Hum Mol Genet 5:1311-1318.
23. Kragten E, Lalande I, Zimmerman K, Roggo S, Schindler P, Muller D, van Oostrum J, Waldmeier P, Furst P. 1998. Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprenyl. J Biol Chem 273:5821-5828.
24. Lassmann H, Bancher C, Breitschopf H, Wegiel J, Bobinski M, Jellinger K, Wisniewski HM. 1995. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Neuropathology 89:35-41.
25. Lubec G, Labudova O, Cairns N, Fountoulakis M. 1999. Increased glyceraldehyde-3-phosphate dehydrogenase levels in the brain of patients with Down's syndrome. Neurosci Lett 260:141-145.
26. Maruyama W, Akao Y, Youdim MBH, Davis BA, Naoi M. 2001. Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(r)salsolinol. J Neurochem 78:727-737.
27. Mazzola JL, Sirover MA. 2001. Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer's disease and Huntington's disease fibroblasts. J Neurochem 76:442-449.
28. Meier-Ruge W, Bertoni-Freddari C. 1996. The significance of glucose turnover in the brain in the pathogenic mechanisms of Alzheimer's disease. Rev Neurosci 7:1-19.
29. Meier-Ruge W, Bertoni-Freddari C, Iwangoff P. 1994. Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer's disease. Gerontology 40:246-253.
30. Meyer-Siegler K, Mauro DJ, Seal G, Wurzer JC, de Riel JK, Sirover MA. 1991. A human nuclear uracil DNA glycosylase is the 37 kDa subunit of glyceraldehyde-3-phosphate dehydrogenase. Proc Natl Acad Sci USA 88:8460-8464.
31. +-binding region (Rossman fold). J Biol Chem 270:2755-2763.
32. Neve RL, Kammesheidt A, Hohmann CF. 1992. Brain transplant of cells expressing the carboxyl-terminal fragment of the Alzheimer amyloid protein precursor cause specific neuropathology in vivo. Proc Natl Acad Sci USA 89:3448-3452.
33. Petersen A, Mani K, Brundin P. 1999. Recent advances on the pathogenesis of Huntington's disease. Exp Neurol 157:1-18.
34. Pietrini P, Alexander GE, Furey ML, Hampel H, Guazzelli, M. 2000. The neurometabolic landscape of cognitive decline: In vivo studies with positron emission tomography in Alzeimer's disease. Int J Psychophysiol 37:87-98.
35. Portera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE. 1995. Evidence for apoptotic cell death in Huntington's disease and excitotoxic animal models. J Neurosci 15:3775-3787.
36. Rapoport SI. 1999. In vivo PET imaging and postmortem studies suggest potentially reversible and irreversible stages of brain metabolic failure in Alzheimer's disease. Eur Arch Psychiatr Clin Neurosci 249(Suppl 3):46-55.
37. Reddy PH, Williams M, Tagle DA. 1999. Recent advances in understanding the pathogenesis of Huntington's disease. Trends Neurosci 22:248-255.
38. Roder HM, Eden PA, Ingram VM. 1993. Brain protein kinase PK 40 converts TAU into PHF-like form found in Alzheimer's disease. Biochem Biophys Res Commun 193:639-647.
39. Roses AD. 1996. From genes to mechanisms to therapies: Lessons learned from neurological disorders. Nat Med 2:267-269.
40. Roses AD, Burke JR, Vance JM, Strittmatter WJ. 1996. A role for GAPDH in apoptosis and neurodegeneration. Nat Med 2:609-610.
41. Salehi A, Swaab DF. 1999. Diminished neuronal metabolic activity in Alzheimer's disease. J Neural Transmiss 106:955-986.
42. Saunders PA, Chalecka-Franaszek E, Chuang D-M. 1997. Subcellular distribution of glyceraldehyde-3-phosphate dehydrogenase in cerebellar granule cells undergoing cytosine arabinoside-induced apoptosis. J Neurochem 69:1820-1828.
43. Saunders PA, Chen R-W, Chuang D-M. 1999. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase isoforms during neuronal apoptosis. J Neurochem 72:925-932.
44. Sawa A, Khan AA, Hester LD, Snyder SH. 1997. Glyceraldehyde-3-phosphate dehydrogenase: Nuclear translocation participates in neuronal and nonneuronal cell death. Proc Natl Acad Sci USA 94:11669-11674.
45. Seal G, Brech K, Karp SJ, Cool BJ, Sirover MA. 1988. Immunological lesions in human uracil DNA glycosylase: Association with Bloom's syndrome. Proc Natl Acad Sci USA 83:2339-2343.
46. Selkoe DJ. 1994. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu Rev Cell Biol 10:373-403.
47. Shulze H, Schuyler A, Stuber D, Dobeli H, Langen H, Huber G. 1993. Rat brain glyceraldehyde-3-phosphate dehydrogenase interacts with the recombinant cytoplasmic domain of Alzheimer's β-amyloid precursor protein. J Neurochem 60:1915-1922.
48. Sirover MA. 1997. Role of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in normal cell function and in cell pathology. J Cell Biochem 66:133-140.
49. Sirover MA. 1999. New insight into an old protein: The functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim Biophys Acta 1432:159-184.
50. Smale G, Nichols NR, Brady DR, Finch CE, Horton WE Jr. 1995. Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 133:225-230.
51. Wahlund LO, Basun H, Almkvist O, Julin P, Axelman K, Shigeta M, Jelic V, Nordberg A, Lannfelt L. 1999. A follow-up study of the family with the Swedish APP 670/671 Alzheimer's disease mutation. Dement Geriatr Cogn Dis 10:526-533.
52. Wu K, Aoki C, Elste A, Rogalski-Wilk AA, Siekevitz P. 1997. The synthesis of ATP by glycolytic enzymes in the postsynaptic density and the effect of endogenously generated nitric oxide. Proc Natl Acad Sci USA 94:13273-13278.
53. Yamatsuji T, Matsui T, Okamoto T, Komatsuzaki K, Takeda S, Fukumoto H, Iwatsubo T, Suzuki N, Asami-Odaka A, Ireland S, Kinane B, Giambarella U, Nishimoto I. 1996. G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutations of APP. Science 272:1349-1352.
54. Yankner BA, Dawes LR, Fisher S, Villa-Komaroff L, Oster-Granite ML, Neve RL. 1989. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245:417-420.
55. Zeitlin S, Liu J-P, Chapman DL, Papaioannou VE, Efstratiadis A. 1995. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntinton's disease homologue. Nat Genet 11:155-163.
56. 2-induced apoptosis in human neuronal cells. Biochem Biophys Res Commun 235:845-848.